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ABSTRACT 
 
Impact of Ibuprofen on the Bone Response to Simulated Resistance Training.  
(April 2011) 
 
Stuart Solomon 
Department of Agriculture and Life Sciences 
Texas A&M University 
 
Research Advisor: Dr. Susan Bloomfield 
Department of Health and Kinesiology 
 
The purpose of this research project was to determine the overall effects of ibuprofen on 
bone formation in response to simulated resistance training in adult female rats. 
Ibuprofen is a common and generally safe non-steroidal anti-inflammatory drug 
(NSAID) that is used to treat musculoskeletal pain and inflammation. The focus of this 
study was to understand how the timing of ibuprofen administration in relation to 
simulated resistance training (SRT) affects the bone response to the training. Young 
adult female Sprague Dawley rats (n=15) were acclimated to a purified rat diet for 4 
weeks. The animals were split randomly into three groups consisting of placebo before 
and after training (n=6), ibuprofen before training/placebo after training (n=4) and 
placebo before training/ibuprofen after training (n=5). Each rat underwent simulated 
resistance training every other day, for a total of 9 exercise sessions. In vivo bone scans 
of the proximal and midshaft tibia were taken before and after treatment in both groups 
by peripheral quantitative computed tomography (pQCT). Data on bone mineral density 
(BMD) and total area of both the proximal tibia and midshaft tibia were acquired. Serum 
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deoxypyridinoline cross-links (DPD), a specific marker of bone resorption, was 
measured to evaluate possible resorption activity in response to training and ibuprofen 
administration. There was no significant difference between groups in total vBMD, 
cancellous vBMD, and cortical vBMD of the proximal tibia, and no significant 
difference between groups in total vBMD and total area of the midshaft area of the tibia. 
However, there was a significant average percent increase in bone density and area in 
both tibia regions for all groups in response to the simulated resistance training. Serum 
DPD levels were not significantly different across groups. These preliminary data do not 
reveal significant effects on bone due to ibuprofen and the timing of its administration 
nor any differences in resorptive activity, but do illustrate a robust bone response to 
SRT. 
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NOMENCLATURE 
 
BMD Bone mineral density 
COX Cyclooxygenase 
COX-2 Cyclooxygenase-2 
DPD Deoxypyridinoline 
IL-1 Interleukin-1 
IL-6 Interleukin-6 
M-CSF Macrophage stimulating factor 
NSAID Non-steroidal anti-inflammatory drug 
PGE2 Prostaglandin E2 
pQCT Peripheral quantitative computerized topography 
RANKL Receptor activator for nuclear factor κ B 
SRT Simulated resistance training 
TNF- α Tumor necrosis factor 
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CHAPTER I 
INTRODUCTION 
 
Ibuprofen is a common over the counter non-steroidal anti-inflammatory drug (NSAID) 
that is used by millions of people worldwide to treat musculoskeletal symptoms such as 
sore muscles and pain from arthritis. Ibuprofen is commonly associated with exercise, as 
people use the drug to attenuate the small aches and pains that are caused by vigorous 
physical activity. Exercise and weight bearing activity is an important factor in achieving 
optimal bone health, as stress on bone that occurs during weight bearing activities 
instigate a repairing bone response that ultimately leads to increased bone density.
(1)
  
Surprisingly, the relationship between such a commonly used drug such as ibuprofen and 
the effects on this bone response to exercise has not yet been studied extensively.  
 
When an anabolic stimulus is applied to bone, such as what occurs during strenuous 
weight bearing exercise, an important regulatory enzyme called cyclooxygenase-2 
(COX-2) is activated. COX-2 in turn synthesizes prostaglandin E2 (PGE2) as a result of 
the initial stimulus.  Ibuprofen works by inhibiting the action of COX-2. Past research on 
Ibuprofen has produced data that suggests the anabolic response to bone from exercise is 
reduced after a single treatment of exercise. It’s clear that PGE2 plays an important role 
in mechanotransduction (how bone translates a mechanical stimulation into a 
biochemical signal.
(2,3,4)
 Past research has attempted to identify explanations for the 
______________ 
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mechanism on how this occurs and how Ibuprofen might alter this process
(5)
. One 
problem is that past studies have focused on an acute treatment of some type of weight 
bearing load on the bone, while the effects due to a chronic and more physiological load 
treatment are still mostly unknown.
(6)
 
 
In addition to the acute stimulus on bone and the resulting release of PGE2, there is an 
additional factor (among others) in the response of bone to more chronic stressors. 
Inflammatory cytokines are released by bone and muscle cells in response to the cellular 
damage incurred by physical exercise and weight bearing activity.
(7,8,9)
 It is believed that 
overtime; these inflammatory cytokines can accumulate in response to chronic training, 
resulting in a resorptive effect on bone.
(5,10,11)
 Even though past research has exhibited an 
overall gain in bone when subjects perform bone stimulating exercise, there still may be 
a measurable amount of bone resorption occurring as well.
(9,12)
 Therefore, the anti-
inflammatory power of Ibuprofen in the chronically trained model may reduce the 
amount of accumulated inflammatory cytokines and resulting bone resorption, 
maximizing positive bone gains due to exercise.
(5)
 
 
Prostaglandin E2 and cyclooxygenase 
PGE2 has a dual effect on bone, having the ability to cause bone formation as well as 
bone resorption.  PGE2 achieves this effect through hormonal regulation, which is a 
byproduct of a network of gap junctions and dendritic connections embedded in bone 
that allows osteocytes buried deep within the bone to communicate with osteoblasts 
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found on the surface.
(13)
 Due to this physiological communication, prostaglandin can 
stimulate osteoblasts to synthesize new bone with decreased concentrations, while higher 
concentrations will stimulate osteoclasts to resorb bone. Weight bearing exercise, such 
as lifting weights and jumping, can stimulate the release of limited amounts of 
prostaglandin, which is the factor that strengthens bone after exercise. The production of 
PGE2 is catalyzed by the enzyme cyclooxygenase (COX). COX consists of two different 
isoforms, COX-1 and COX-2. COX-1 is expressed constantly and acts homeostatically 
by maintaining COX levels in bone. The COX-2 isoform is not present in most of the 
tissues of the body and is the most active compound in forming PGE2 in a response to 
exercise in bone.
(9)
 While levels of COX-1 remain relatively constant, and COX-1 is 
always produced, COX-2 is produced in response to a stimulus (such as exercise) and 
has varying levels as a result.
(2,14)
 
 
Mechanical load and NSAIDs: The effect on bone 
When a bone experiences a stress from a load, a large stimulus is produced over the 
entire cell lining surrounding the bone, which allows for the reorganization of the actin 
cytoskeleton in order to stimulate the production of PGE2.
(15)
 Previous research has 
shown that bone can exhibit a significant increase of PGE2 in less than five minutes, 
while levels are brought back down to baseline within fifteen minutes after the load in 
cultured cells.
(6,16)
 The main response of bone to a mechanical load has been thought to 
come from this quick, initial increase in prostaglandin levels.
(6,17)
 In a previous study, it 
has been shown that when indomethacin, a non-selective COX inhibitor with a COX-
  4 
1/COX-2 ratio of 2 (meaning it inhibits COX-1 more than COX-2), is administered 3 hrs 
before load there is inhibition of new bone formation; however, if the indomethacin is 
administered 6 hours after loading there is no inhibitory response to mechanical load.
(6)
 
This suggests that the COX inhibiting nature of NSAIDs can give us clues as to how 
PGE2 production plays a role in bone formation.
 
It would seem that in order to have an 
increase in PGE2, there must be an increase in COX-2 to produce it. However, it has 
been shown that mechanically induced COX-2 production is not essential for loading-
induced bone formation.
(18)
 It has also been shown that fluid shear strain does not cause 
in increase in the production of COX-2 until 30-90 minutes after the mechanical load 
when delivered to cultured cells.
(16,19)
 
 
Current research on the effects of NSAIDs on COX-2 has shown varying results based 
on the time of administration. When rats were given NS-398, a specific COX-2 inhibitor, 
30 minutes before a mechanical load was placed on the ulna and tibia, there was not a 
decrease in the bone response to the acute load on the bone. However, the anticipated 
reduction of bone mass occurred when the NS-398 was administered three hours before 
the load. Because NS-398 reaches its peak serum levels after 30 minutes, it was 
hypothesized that the NSAID would have the same effect whether it was given three 
hours or 30 minutes before the mechanical load
(16)
. A recent finding in cultured cells has 
shown that mechanical loading on bone initiates an intracellular secretion of 
prostaglandin in response to the load, as opposed to stimulating prostaglandin 
production. This suggests that in order for prostaglandin to be suppressed, the inhibition 
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of the production of prostaglandin must occur a long time before the mechanical load is 
performed.
(18) 
However, the initial release of PGE2 that occurs within the first fifteen 
minutes of a mechanical load may not be the only timeframe in which prostaglandin has 
an anabolic effect. When a non-specific NSAID was administered six hours post-
mechanical load in conjunction with NSAID administration for eight days post-load, the 
anabolic effect of the acute load on the bone was returned to the state measured before 
the load. In a group that received the same treatment but with a placebo for the eight 
days post-load, the anabolic response on the bone was still measurable.
(6)
 This suggests 
that there is a lingering window of opportunity for prostaglandin to have an anabolic 
effect on bone outside of the initial release. 
 
Inflammatory cytokines and exercise 
Inflammatory cytokines are proteins that are released by the immune system in response 
to a stressor. In the case of exercise, inflammatory cytokines are released by skeletal 
muscle when the bone is compressed and strained during a weight bearing 
activity.
(11,20,21) 
Inflammatory cytokines work on bone by stimulating osteoclasts to raise 
their activity, inducing bone resorption.
(8,18) 
The three most common inflammatory 
cytokines involved with bone resorption are Interleukin-1 (IL-1), Interleukin-6 (IL-6) 
and tumor necrosis factor (TNF- α).(18,22,23) The effect of these cytokines on bone are 
mediated by receptor activator for nuclear factor κ B (RANKL) and macrophage 
stimulating factor (M-CSF) produced by osteoblasts for osteoclastogenesis- the synthesis 
of new osteoclasts.  IL-1 and TNF-α work together to elicit a marked increase in 
  6 
RANKL levels, thus showing proinflammatory regulation of osteoclast differentiation 
and activity through RANKL.
(5,18)  
IL-6 appears to have no effect on RANKL regulation, 
but has been shown to affect bone resorption indirectly.
(18)
 IL-6 stimulates bone 
resorption by activating a biochemical cascade of other inflammatory and 
proinflammatory cytokines such as IL-1 and TNF-α.(21) 
 
There is a marked increase in both serum TNF-α and IL-1 after exercise.(21) One session 
of intense resistance exercise in a human study yielded serum levels of IL-6 close to 
seven times higher than baseline one hour after the training.
(3)
 This increase in cytokines 
due to exercise has been thought to be a result of lipopolysaccharide leakage from the 
intestines, in addition to proinflammatories leaked from the muscle during exercise and 
contraction.
(24,25)
 Because of the powerful effect that cytokines have on bone resorption, 
an individual who exercises regularly will have higher cytokine levels due to the chronic 
inflammation, and as a result, more bone resorption. The effect of NSAIDs on exercise-
induced cytokines could measurably reduce chronic levels of IL-6 that have accumulated 
from exercise.
(26,27,28)
 
 
NSAIDs and chronic resistance training 
The use of NSAIDs to reduce inflammatory cytokine levels in an attempt to curb chronic 
bone resorption has been studied recently. It was demonstrated by Kohrt et al. that a 
positive effect on bone could be achieved when NSAIDs were administered to 
chronically trained individuals after exercise.
(5)
 Past research has shown that when 
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NSAIDs are administered after a single acute mechanical load, the effects observed are 
similar to the placebo group.
(5)
 One proposed process of how this occurs is that the 
positive effect on bone from the NSAIDs is due to the drug reducing unusually high 
inflammatory cytokine levels and suppressing the aforementioned acute burst of 
exercise-induced bone resorption.
(5,29)
  
 
Although NSAIDs such as Ibuprofen have been shown to reduce bone resorption from 
exercise-induced inflammatory cytokines, the mechanism involved in this process may 
be difficult to analyze, due to the many factors involved in the cytokine production from 
exercise. A study involving marathon runners showed a significant increase in 
endotoxins in a group that was administered ibuprofen.
(20,25)
 One proposed reason for 
this delineation from previous data is that Ibuprofen reduces the glomerular filtration 
rate (GFR) of the kidneys, reducing their ability to clear inflammatory cytokines from 
the body as efficiently.
(31)
 Because of conflicting results and their complicated 
mechanism of use, the study of NSAIDs such as Ibuprofen should be done under as 
controlled conditions as possible. 
 
Conclusion 
In summary, the study of the effects of Ibuprofen on bone involves several physiological 
processes including local and systemic factors. In order to understand this phenomenon 
fully, all of these physiological factors should be taken into account. It should also be 
explored whether or not the timing of administration of the Ibuprofen has a noticeable 
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difference to the effect on bone. Finally, the effects of Ibuprofen on bone in response to 
chronic weight bearing exercise should be compared to that of an acute treatment of 
weight bearing stimulus. For individuals that put regular stress on their bones due to 
exercise, research on a simple yet effective way to maximize bone formation will be 
beneficial.  If a better understanding of how ibuprofen affects bone remodeling in 
response to exercise can be achieved, we can potentially come closer to providing a 
recommendation to individuals that take NSAIDs before or after exercise on when to 
take them to maximize bone health. 
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CHAPTER II 
METHODS 
 
Animal information     
Young adult Sprague-Dawley rats were used in this study as an animal model to 
demonstrate the effects of ibuprofen on the bone response to simulated resistance 
training (SRT). Sprague-Dawley rats have consistently demonstrated a robust bone 
response to voluntary and simulated resistance exercises in our past research.
(4,12,32)
 
Finally, due to the multiple serum analyses that were required during this study, rats, 
rather than mice, were ideal because of the larger volumes of blood that can be collected 
from rats.  
 
Upon arrival, 15 female Sprague-Dawley rats, 4.5-months old at arrival, were housed at 
an animal facility on Agronomy Road, two to a cage, on a 12:12 hour light:dark cycle.   
After one week of acclimation, the rats were rank-ordered by body mass and then block 
assigned to one of the 3 experimental groups. This block randomization strategy helps 
assure groups with roughly equal mean body weight, which is important since body 
mass is a strong predictor of bone mass. One group received a placebo solution (1 ml of 
vehicle [methylcellulose] without ibuprofen) before resistance exercise and after 
resistance exercise, one group received ibuprofen (1 ml of vehicle [methylcellulose] with 
ibuprofen) before resistance exercise and the placebo after resistance exercise, and one 
group received the placebo before resistance exercise and ibuprofen after resistance 
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exercise. Table 1 shows the groups in the experiment. Those groups that received 
ibuprofen were given a 30 mg/kg dose. The literature states that a dose between 10mg/kg 
and 30mg/kg is safe
(33)
.  Previous research has effectively used 30 mg/kg for fracture 
healing studies
(27,30) 
and it has been stated that the ulcerogenic dose in rats is 455 mg/kg 
(4 daily doses)
(34,35)
. The animals in this study will only be receiving a dose of 30 mg/kg 
3 days per week, which is well below the 455 mg/kg ulcerogenic dose. 
 
 
 
Table 1. Experiment Groups 
Group Before Ex After Ex 
P:P Placebo Placebo 
I:P Ibuprofen Placebo 
P:I Placebo Ibuprofen 
 
 
 
Starting at roughly 5 months of age, all rats began their simulated resistance training 
regimen, which was performed 3 days per week.  Training continued for 5 weeks, as a 
robust bone response after this period of time has been previously documented. 
(4,12) 
All 
animals received approximately 1 ml of vehicle (methylcellulose) with or without 
ibuprofen by oral gavage before and after each training session. 
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Number of animals 
9 rats per group provides adequate statistical power (0.74 – 1.00) to detect changes of 
8% in total and cortical BMD and changes of 15% in cancellous BMD at the proximal 
tibia, as measured by pQCT.  Total, cancellous and cortical BMD determined by pQCT 
are the key variables we track to assess loading induced changes in bone mass.  We have 
previously determined population variance on adult rats for these pQCT-derived 
measures to range from 3% for cortical BMD to 11% for cancellous BMD.  This thesis 
provides results from only the first cohort of animals in the whole study. Therefore, the 
statistical power to detect group differences is much lower than desirable; hence these 
data must be considered preliminary in nature.  
 
Procedures 
In-vivo pQCT scan:  Measures of tibial bone density and geometry were taken in-vivo 
using our peripheral quantitative computed tomography (pQCT) device (XCT Research 
M Stratec; Norland Corp., Fort Atkinson, WI). pQCT scans are an ideal way to measure 
bone density and geometry in animals because they can be performed in vivo before and 
after treatment, provideing a high statistical power. Another large advantage of pQCT is 
its ability to differentiate between cancellous and cortical bone compartments within the 
same slice, as opposed to 2-D methods like dual energy x-ray absorptiometry.   Animals 
were anesthetized with inhaled isofluorane (to effect) and scan slices were taken at both 
the metaphyseal (3.25 3.75, 4.25, 4.75 mm distal to a reference line set at the knee joint) 
and diaphyseal (50% total bone length) regions, with voxel size of 100um.  Total scan 
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time was approximately 20 minutes from time of scout view until scanning is complete.  
Key outcome variables include total, trabecular, and cortical volumetric bone mineral 
density (vBMD); total and cortical area, total bone mineral content (BMC); and cross-
sectional moment of inertia (CSMI) and section modulus, which combines CSMI and 
vBMD data to provide an estimate of bone strength. This study reports total, trabecular 
and cortical vBMD of the proximal tibia and total vBMD and total area of the midshaft 
tibia. 
 
Simulated resistance training: Animals received SRT sessions every other day for 3 
weeks for a total of 9 SRT sessions. After the animal was anesthetized, electrodes were 
placed across the sciatic nerve in order to stimulate the sciatic nerve and generate a 
contraction of total leg musculature. The hip and knee joints were immobilized to isolate 
only the movement of the talocrural (ankle) joint. The foot was attached to a servomotor 
with measurable torque inputs and outputs, enabling us to measure the force the foot 
enacted on the foot plate during isometric contraction, and the amount of force placed 
against the foot by the foot plate during eccentric contraction. Training intensity for both 
types of muscle contraction was standardized for each animal at 75% of their peak 
isometric contraction strength. Each SRT session consisted of 4 sets of 5 contractions for 
a total of 20 contractions per session. Each contraction consisted of 1 isometric 
contraction followed immediately by a 1 second eccentric contraction. Range of motion 
for the eccentric contraction occurred from -40° to 40°. 
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Blood Draws for interleukin-6 assays: Blood draws were taken from the saphenous vein 
after the 3
rd
 training session, within the first week, and 3 sessions before the final 
session, within the 5
th
 week.  Animals were put administered isoflourane in order to 
obtain the blood samples.  Approximately 250µl was obtained.  Rats were anesthetized 
with inhaled isofluorane (to effect) and a tourniquet tied around the upper leg to apply 
intermediate pressure; the lower leg was shaved to aid in visualizing the saphenous vein, 
and venous blood collected with a 26 ga needle into a microfuge tube.   Twenty-four 
hours after the final training session (day 21), rats were anesthetized and euthanized by 
decapitation; cardiac serum was collected and tibia and femurs cleaned of soft tissue, 
wrapped in saline-soaked gauze and frozen at -80º until further analysis.   
 
Assay for interleukin-6: Standard ELISA procedures were planned for interleukin-6 
assays utilizing kits from ImmunoDiagnostics Quantikine.    Duplicates of a pooled 
serum sample in each separate kit were to be used in each assay in order to quantitate 
inter-kit CV’s, in addition to the standards for the calibration curve.    All samples were 
to be organized so that any one rat’s samples would all be assayed with one kit.  
 
Assay for deoxypyridinoline: Deoxypyridinoline (DPD) was chosen to evaluate bone 
resorption in our experimental groups because DPD is a more accurate measure of 
specific bone resorption when compared to alternatives such as hydroxyproline
(36)
. Free 
serum DPD was measured from cardiac serum collected on day 21 by ELISA assay in 
order to evaluate if bone resorption was occurring as a result of SRT (Microvue DPD 
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assay, Quidel Corp, Mountain View, CA). The intra-assay CV was ~12% and the inter-
assay CV was ~9%.  Samples were run as duplicates with an incubation time of 23 
hours. 
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CHAPTER III 
RESULTS 
 
Reflection on methods 
Although the animal training and administration of ibuprofen proceeded with only a few 
obstacles, the IL-6 ELISA assay that was originally planned for this study presented us 
with challenges. We were able to generate an excellent standard curve, but the values we 
generated for our cardiac serum samples clustered in the bottom 10% of the standard 
curve. As a result, we were not confident in the data for serum IL-6. Since we have very 
limited volumes of serum from the pre- and post-exercise time points, we could not risk 
re-running this assay without more serious troubleshooting. Although we are still 
hopeful that the IL-6 data can be generated in the future, there simply was not enough 
time to address the problems caused by the assay kit before these data were to be 
presented at Student Research Week and included in this undergraduate thesis project. 
Fortunately, other aspects of the study proceeded as planned, with the pQCT scans 
contributing compelling data. From that point, the study of this thesis project shifted 
from the relationship between bone gains and serum IL-6 levels to the effects of 
ibuprofen on bone density and geometry as measured by pQCT and any detectable bone 
resorption activity that be caused by transient elevation in cytokines after exercise as 
measured by serum DPD levels. 
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pQCT results 
Figure 1 shows the total bone mineral density (vBMD) of the proximal tibia averaged 
from four scans of pQCT. There was not a significant difference between ibuprofen 
groups, but there was a significant average increase in vBMD for all groups between pre 
and post exercise. Figure 2 shows the vBMD of the cancellous compartment of the 
proximal tibia. There was not a significant difference of gain in bone between groups, 
but there was a significant percent increase in vBMD for all groups from pre to post 
exercise. Figure 3 shows the vBMD of the cortical shell of the proximal tibia between 
groups. There was not a significant difference between groups for the cortical shell, but a 
significant increase in cortical shell vBMD occurred from pre to post exercise. Figure 4 
shows the total vBMD of the midshaft of the tibia. Although the three groups were not 
significantly different from one another, there was a significant change for all of the 
groups between pre and post exercise. Figure 5 shows the total area (in mm
2
) of the 
midshaft of the tibia. There was not a significant difference between ibuprofen groups in 
tibia midshaft area, but a significant percent increase occurred from pre to post exercise. 
 
Deoxypydinoline results 
There were no significant differences in the serum levels of DPD between all groups, as 
measured on day 21 of the experiment (post exercise). Table 2 shows average DPD 
values of the three experimental groups. 
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FIG. 1. Total vBMD of the proximal tibia between ibuprofen groups. Although there was no significant 
difference between groups, there was a significant percentage gain in total vBMD for all of the groups 
between pre and post exercise 
 
 
 
 
 
 
     
 
FIG. 2. Cancellous vBMD of the proximal tibia between ibuprofen groups. Although there was no 
significant difference between groups, there was a significant percentage gain in cancellous vBMD for all 
of the groups between pre and post exercise 
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FIG. 3. Cortical vBMD of the proximal tibia between ibuprofen groups. There was not a significant 
difference between the three groups, but a significant gain in cortical vBMD was seen from pre to post 
exercise. 
 
 
 
 
FIG. 4. Total vBMD of the midshaft tibia between ibuprofen groups.  Although there was no significant 
difference between groups, there was a significant percentage gain in midshaft vBMD for all of the groups 
between pre and post exercise. 
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FIG. 5. Total area of the midshaft tibia between ibuprofen groups. Although there was no significant 
difference in gain in area of bone between the groups, there was a significant increase in area for all of the 
groups from pre to post exercise. 
 
 
 
 
 
Table 2. Deoxypyridinoline Levels 
 P:P I:P P:I 
Deoxypyridinoline (pmol/ml) 5.38 ± 1.78 5.92 ± 2.21 5.12 ±1. 38 
Data shown as mean ± SD. No significant differences were found among the 3 group means, by 
one-way ANOVA 
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CHAPTER IV 
DISCUSSION AND CONCLUSIONS 
 
Discussion 
This study was the first to evaluate a chronic controlled resistance training model with 
ibuprofen in animals. Past research has established that simulated resistance training is 
an effective treatment in producing a measurable change in bone density and geometry, 
and these results further support these previous findings
(12)
. PGE2 has been identified as 
a major contributor to bone growth in response to training
(2,4)
. Based on the findings 
from previous studies on how NSAIDs interfere with the release of PGE2 and its 
resultant effects on bone, we hypothesized that a more chronic training model would 
reveal more definitive information on how this process occurs
(6,16,18)
. After the 21 days 
of training, there was a significant gain in bone density and favorable changes in cross-
section geometry for all rats in all groups. This is important, as SRT has been established 
as a more physiological loading model in animals. By mimicking the stresses on bone 
that might be seen in the real world, while having the ability to quantitatively measure 
the amount of torque generated by the muscles acting on the bone, we can have a more 
controlled bone forming treatment in addition to increasing the credibility of our 
findings due to the physiological relevance of the treatment. 
 
Even though there was a marked increase in bone from pre to post training in the 
animals, the effects of ibuprofen that have been demonstrated in past research were not 
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observed in this study. Chow and Chambers revealed how a non-selective 
cyclooxygenase inhibitor reduced the gains in bone provided by an acute bout of 
mechanical loading
(6)
. Other studies expanded on this finding, demonstrating how COX-
2 is especially important in growth of lamellar bone by using NS-398, a selective COX-2 
inhibitor
(16,37)
. Although we expected to observe similar results due to the mostly COX-2 
inhibiting nature of ibuprofen, we could not reproduce previous data. One possible 
reason for this is that the simulated resistance training was too strong of a mechanical 
load, causing an overwhelming bone response that would mask any more subtle 
differences that would be caused by ibuprofen. We chose 75% of the isometric 
maximum contraction based on our previous procedures and a small pilot study that 
preceded this experiment, but it still may have been too intense
(12)
. In addition, our 
previous studies used an eccentric contraction ranging from -20° to 20° range of motion, 
where we used -40° to 40° range of motion, resulting in higher eccentric torques, and 
therefore a more robust stimulus delivered to the bone. All of these factors contributed to 
an almost extreme gain in bone density and geometry, which may have masked effects 
of ibuprofen that were occurring.   
 
Another possible reason we did not observe any effects of ibuprofen in this study was 
the small sample size. Due to time constraints, only the first cohort of the experimental 
animals was included in this report. The second cohort, which will double the total 
number of animals in the study, was completed 1 week before the submission of this 
thesis. Due to the low numbers of animals, there may not have been enough statistical 
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power to see a significant difference in bone gains between ibuprofen groups. Finally, 
there was a small amount of error in administering the ibuprofen in the anesthetized 
animal in the first week of the study. Some of the animals may have aspirated a small 
amount of liquid ibuprofen during oral administration. The ibuprofen was administered 
by means of gavage in order to deliver the ibuprofen directly to the stomach and control 
time of delivery. This method was chosen to best mimic the human response to NSAIDs 
taken orally. About 10 days into training, these procedural errors were corrected by 
holding the animal in an upright position in order to prevent regurgitation of the 
ibuprofen resulting in inhalation. However, presumably due to first days of training and 
possible ibuprofen aspiration, the animals that received ibuprofen after training had a 
lower body weight profile than the other groups. These differences were not statistically 
significant, but lower body weights may have reduced potential gains in bone for the 
ibuprofen after exercise group. We expected this group to have a higher gain in bone 
when compared to the other groups. 
 
The analysis of serum DPD levels did not produce a significantly different result, and 
levels of DPD in our animals were in the acceptable range for young adult female 
rats
(36)
. This result suggests that SRT with or without ibuprofen administration does not 
have a measurable effect on bone resorption.  It is possible that because cardiac serum 
was used, the exercising of one leg was not enough to see a significant change in 
systemic levels of DPD. Perhaps a more interesting result would have been observed if 
serum from the local site (like the saphenous vein) was used to analyze DPD levels. 
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Another possible explanation for the lack of differing DPD levels is that the simulated 
resistance training had such a bone stimulating effect that it masked any possible 
detriment on the bone that would be caused by accumulating levels of IL-6 and other 
inflammatory cytokines. It will be interesting in the future to compare cytokine levels 
with the level of bone resorption markers to see if there is a relationship between the 
effects of simulated resistance training and accumulation of inflammatory cytokines. 
 
Conclusion 
Simulated resistance training in a full weight bearing rat model produces a highly potent 
gain in bone with a more physiological form of mechanical loading than those used in 
previous models. These preliminary data did not reveal significant effects on bone due to 
ibuprofen and the timing of its administration with several possible factors being the 
cause of these unanticipated results. Given the compelling previous data in the published 
literature, it will be important to continue to pursue interactive effects of NSAIDs and 
exercise on bone outcomes. 
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